Repare Therapeutics (RPTX)
(Delayed Data from NSDQ)
$3.94 USD
+0.04 (1.03%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $3.94 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.85 |
EPS Last Quarter | 0.30 |
Last EPS Surprise | 400.00% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.35 |
Next Year | -3.21 |
EPS (TTM) | -1.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.78M | 4.15M | 58.72M | 22.27M |
# of Estimates | 4 | 4 | 6 | 3 |
High Estimate | 9.10M | 9.10M | 79.70M | 40.00M |
Low Estimate | 1.00M | 1.50M | 40.00M | 8.00M |
Year ago Sales | 30.25M | 2.16M | 51.13M | 58.72M |
Year over Year Growth Est. | -87.52% | 92.13% | 14.83% | -62.07% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.85 | -0.85 | -2.35 | -3.21 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.86 | -0.85 | -2.20 | -3.02 |
High Estimate | -0.73 | -0.77 | -2.06 | -2.44 |
Low Estimate | -0.90 | -0.93 | -2.92 | -4.09 |
Year ago EPS | -0.28 | -0.45 | -2.23 | -2.35 |
Year over Year Growth Est. | -203.57% | -88.89% | -5.38% | -36.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.85 | -0.85 | -2.35 | -3.21 |
7 Days Ago | -0.85 | -0.85 | -2.35 | -3.21 |
30 Days Ago | -0.85 | -0.85 | -2.35 | -3.26 |
60 Days Ago | -0.86 | -0.86 | -2.42 | -3.29 |
90 Days Ago | -0.86 | -0.87 | -2.74 | -3.08 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.85 | -0.85 | -2.35 | -2.44 |
Zacks Consensus Estimate | -0.85 | -0.85 | -2.35 | -3.21 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 23.89% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.30 | -0.67 | -0.45 | -0.28 | NA |
Estimate | -0.10 | -0.56 | -0.86 | -0.83 | NA |
Difference | 0.40 | -0.11 | 0.41 | 0.55 | 0.31 |
Surprise | 400.00% | -19.64% | 47.67% | 66.27% | 123.58% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more